MA H4865 | 2017-2018 | 190th General Court

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Engrossed on July 31 2018 - 50% progression, died in committee
Action: 2018-08-06 - Read; and referred to the committee on Senate Ways and Means
Pending: Senate Ways and Means Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Substituted by the House, on motion of Mr. Speliotis of Danvers, for a bill with the same title (House, No. 3644). July 31, 2018.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Relative to certain genetically targeted drug coverage for Duchenne Muscular Dystrophy

Sponsors


History

DateChamberAction
2018-08-06SenateRead; and referred to the committee on Senate Ways and Means
2018-07-31HousePassed to be engrossed
2018-07-31HouseOrdered to a third reading
2018-07-31HouseSubstituted for H3644

Same As/Similar To

H3644 (Similar To) 2018-07-31 - Amended by substitution of a bill with the same title, H4865
H626 (Similar To) 2018-05-24 - Accompanied a study order, see H4528
H1332 (Similar To) 2018-06-25 - Accompanied a study order, see H4654
S1384 (Similar To) 2018-04-26 - Accompanied a study order, see S2491
H1372 (Similar To) 2018-06-25 - Accompanied a study order, see H4654
H4977 (Similar To) 2019-01-09 - Signed by the Governor, Chapter 419 of the Acts of 2018

Massachusetts State Sources


Bill Comments

feedback